ArticleBMC gastroenterology2024

Comparative efficacy and safety of Sofosbuvir/Velpatasvir and Danoprevir for the treatment of chronic hepatitis C: the real-world data in China.

Yunjing Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.